Profound Medical Corp. (PROF) Dropped Despite High Potential
Grow Funds, an investment Advisor, released its Q1 2026 investor letter for “GROW Small Cap Equity Long/Short Fund”. A copy of the letter can be downloaded here.
Profound Medical Corp. (PROF)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 1,199,564 | $7,975,948 | +8% | 0.06% |
| 2. | Timelo Investment Management Jean-Francois Tardif | 1,114,967 | $7,414,531 | 2.13% | |
| 3. | Ardsley Partners Philip Hempleman | 575,000 | $3,823,750 | 0.4% | |
| 4. | First Eagle Investment Management Jean-Marie Eveillard | 440,207 | $2,927,377 | +37% | 0% |
| 5. | DAFNA Capital Management Nathan Fischel | 260,360 | $1,731,394 | -2% | 0.33% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.73 | 12,027 | $56,887.71 | 587,089 | 2025-05-16 | Filing | |
| $4.33 | 10,003 | $43,262.98 | 575,062 | 2025-05-15 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 521,132 | $3,022,566 | 1.23% | |
| 2. | 161,631 | $888,081 | 0% | |
| 3. | 21,657 | $125,613 | 0% | |
| 4. | 11,375 | $65,975 | 0.04% | |
| 5. | 0 | $0 | 0% |
News See All
Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript
Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for standing by.
Profound Medical Corp. (NASDAQ:PROF) Q3 2025 Earnings Call Transcript
Profound Medical Corp. (NASDAQ:PROF) Q3 2025 Earnings Call Transcript November 13, 2025Profound Medical Corp. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.38.
Profound Medical Corp. (NASDAQ:PROF) Q2 2025 Earnings Call Transcript
Profound Medical Corp. (NASDAQ:PROF) Q2 2025 Earnings Call Transcript August 14, 2025Profound Medical Corp. misses on earnings expectations. Reported EPS is $-0.52 EPS, expectations were $-0.43.
Profound Medical Completes First Commercial BPH Treatment With New TULSA-AI Volume Reduction Module
Profound Medical Corp. (NASDAQ:PROF) is one of the best Canadian stocks with huge upside potential.
12 Best Canadian Stocks With Huge Upside Potential
Earlier on May 29, Invesco’s Brian Levitt appeared on CNBC's 'The Exchange' to discuss how he thinks now is the time to diversify your portfolio into other parts of the world.
Profound Medical Corp. (NASDAQ:PROF) Q1 2025 Earnings Call Transcript
Profound Medical Corp. (NASDAQ:PROF) Q1 2025 Earnings Call Transcript May 9, 2025 Operator: Good day, and thank you for standing by.
Profound Medical Corp. (NASDAQ:PROF) Q4 2024 Earnings Call Transcript
Profound Medical Corp. (NASDAQ:PROF) Q4 2024 Earnings Call Transcript March 6, 2025Profound Medical Corp. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.31.
Profound Medical Corp. (NASDAQ:PROF) Q3 2024 Earnings Call Transcript
Profound Medical Corp. (NASDAQ:PROF) Q3 2024 Earnings Call Transcript November 10, 2024 Operator: Good day and thank you for standing by.
Profound Medical Corp. (NASDAQ:PROF) Q2 2024 Earnings Call Transcript
Profound Medical Corp. (NASDAQ:PROF) Q2 2024 Earnings Call Transcript August 8, 2024 Operator: Welcome to the Profound Medical Second Quarter 2024 Financial Results conference call.
Hedge Fund Resource Center